Intravenous mycophenolate mofetil immunosuppressant injection, billed per 10 mg

This code represents the injectable form of mycophenolate mofetil, an immunosuppressant medication. It is primarily used to prevent organ rejection in patients who have received solid organ transplants, such as kidney, heart, or liver transplants. Mycophenolate mofetil works by inhibiting the proliferation of lymphocytes, which are key cells involved in the immune response.

Use this code when reporting the administration of injectable mycophenolate mofetil in a clinical setting, typically for transplant recipients unable to take oral formulations. Documentation should clearly indicate the drug name, dosage administered (10 mg increments), and the route of administration (intravenous). This code is appropriate for both initial dosing and maintenance therapy as prescribed by the transplant team.

• Report units based on 10 mg increments. For example, 100 mg would be 10 units.
• Do not confuse with oral mycophenolate mofetil (J7517) or mycophenolic acid (J7518).
• Ensure supporting documentation includes the medical necessity for the injectable form over oral administration, such as malabsorption or NPO status.